Wird geladen...
Dual bronchodilation vs triple therapy in the “real-life” COPD DACCORD study
BACKGROUND: No observational studies have evaluated the “real-world” effectiveness of dual bronchodilation comprising a long-acting β(2)-agonist plus a long-acting muscarinic antagonist vs that of triple therapy (long-acting β(2)-agonist plus long-acting muscarinic antagonist plus inhaled corticoste...
Gespeichert in:
| Veröffentlicht in: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove Medical Press
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6113909/ https://ncbi.nlm.nih.gov/pubmed/30197512 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S169958 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|